Clinical Trial

Luminal Breast Cancer Cryoablation

Study acronym: LUBRECA
Recruiting
View on ClinicalTrials.gov →
Summary
LUBRECA will evaluate the safety and efficacy of cryoablation with liquid nitrogen to treat cT1cN0 luminal breast cancer diagnosed in postmenopausal women
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-17
Trial Details
NCT Number NCT07447414
Lead Sponsor Lucía Graña López
Conditions Breast Cancer, Breast Cancer (Early Breast Cancer)
Enrollment 140 participants
Start Date 2026-04-08
Primary Completion 2028-09 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-16